Related Experiment Video
Updated: Dec 6, 2025
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
[Effectiveness of intraperitoneal chemotherapy for t4 colon cancer]
Yu A Shelygin1,2, O I Sushkov1, M A Sukhina1,2
1Ryzhikh National Medical Research Centre for Coloproctology, Moscow, Russia.
Objective:
To determine the effect of intraperitoneal chemotherapy (IPC) with mitomycin C on expression of intraperitoneal cancer cells markers in patients with T4 colon cancer.
Material And Methods:
For the period from January 2019 to April 2020, 65 patients with T4 colon cancer were included in prospective comparative study. There were 46 patients in the main group and 19 patients in the control group. In the main group, surgical procedure was followed by IPC with mitomycin C. No IPC was performed in the control group. An effectiveness of IPC was evaluated using CD133, CD24, CD26, CD44, CD184 markers expression in peritoneal lavages.
Results:
Significant between-group differences were observed for CD133 (p=0.0168), CD24 (p=0.0455) and CD44 (p=0.0012). There was a tendency to decrease in the level of CD184 expression in both groups in the second lavage (p=0.0605).
Conclusion:
IPC in patients with T4 colon cancer can reduce the expression and proliferative potential of free cancer cells.
